Authors:
BALLARON SJ
SHEETS M
MOLLISON KW
WARRIOR U
FALTYNEK C
DONNELLY J
PUTMAN B
WIEDEMAN P
MADAR D
TU N
HAJDUK P
DJURIC S
LULY J
TREVILLYAN J
Citation: Sj. Ballaron et al., IRREVERSIBLE INHIBITION OF P56(LCK) TYROSINE KINASE BY METHYL 3-(N-ISOTHIAZOLONE)-2-THIOPHENECARBOXYLATE, The FASEB journal, 11(9), 1997, pp. 2810-2810
Authors:
RAO PN
CAI X
VENKATARAMANAN R
PLATT JL
DEMETRIS A
THUNBERG A
FALTYNEK C
STARZL T
KUMAR P
Citation: Pn. Rao et al., REDUCTION OF FK-506 REQUIREMENTS BY COMBINATION WITH POLYETHYLENE-GLYCOL SUPEROXIDE-DISMUTASE IN ORTHOTOPIC RAT-LIVER TRANSPLANTATION, Journal of allergy and clinical immunology, 95(6), 1995, pp. 1276-1281
Authors:
HILL RJ
GRANT AM
VOLBERG W
RAPP L
FALTYNEK C
MILLER D
PAGANI K
BAIZMAN E
WANG S
GUILES JW
KRAFTE DS
Citation: Rj. Hill et al., WIN-17317-3 - NOVEL NONPEPTIDE ANTAGONIST OF VOLTAGE-ACTIVATED K-LYMPHOCYTES( CHANNELS IN HUMAN T), Molecular pharmacology, 48(1), 1995, pp. 98-104
Authors:
LEHR R
MA YG
WANG S
WANG XM
KRATZ D
BRAKE P
FALTYNEK C
STEVIS P
Citation: R. Lehr et al., A COMPARISON OF NATIVE P56LCK WITH PURIFIED HUMAN RECOMBINANT LCK EXPRESSED IN A BACULOVIRUS-INSECT CELL SYSTEM, The FASEB journal, 8(7), 1994, pp. 10001433-10001433
Authors:
PERRY G
KELSEY L
FALTYNEK C
JACKSON J
TALMADGE JE
Citation: G. Perry et al., HEMATOPOIETIC, LYMPHOPOIETIC AND IMMUNOTHERAPEUTIC PROPERTIES OF RECOMBINANT HUMAN INTERLEUKIN-7 POST AGGRESSIVE SPLIT-DOSE POLYCHEMOTHERAPY, Journal of cellular biochemistry, 1994, pp. 15-15
Citation: T. Bui et al., DIFFERENTIAL DISPOSITION OF SOLUBLE AND LIPOSOME-FORMULATED HUMAN RECOMBINANT INTERLEUKIN-7 - EFFECTS ON BLOOD LYMPHOCYTE POPULATION IN GUINEA-PIGS, Pharmaceutical research, 11(5), 1994, pp. 633-641
Authors:
TALMADGE JE
JACKSON JD
KELSEY L
BORGESON CD
FALTYNEK C
PERRY GA
Citation: Je. Talmadge et al., T-CELL RECONSTITUTION BY MOLECULAR, PHENOTYPIC, AND FUNCTIONAL-ANALYSIS IN THE THYMUS, BONE-MARROW, SPLEEN, AND BLOOD FOLLOWING SPLIT-DOSE POLYCHEMOTHERAPY AND THERAPEUTIC ACTIVITY FOR METASTATIC BREAST-CANCERIN MICE, Journal of immunotherapy with emphasis on tumor immunology, 14(4), 1993, pp. 258-268
Authors:
TALMADGE JE
KELSEV L
FALTYNEK C
JACKSON J
PERRY G
Citation: Je. Talmadge et al., IMMUNORESTORATIVE AND IMMUNOTHERAPEUTIC PROPERTIES OF RECOMBINANT HUMAN INTERLEUKIN-7 FOLLOWING SPLIT-DOSE POLYCHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000241-10000241
Authors:
JACKSON JD
YAN Y
KELSEY L
FALTYNEK C
TALMADGE JE
Citation: Jd. Jackson et al., MOBILIZATION OF HEMATOPOIETIC PROGENITORS FOLLOWING IL-7 ADMINISTRATION POSTCHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000368-10000368
Authors:
PERRY GA
GORDY C
FALTYNEK C
JACKSON JD
TALMADGE JE
Citation: Ga. Perry et al., PHENOTYPIC ANALYSIS OF IMMUNE RECONSTITUTION AFTER POLYCHEMOTHERAPY AND TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-7 (RHIL7), Blood, 82(10), 1993, pp. 10000519-10000519